Immucor Inc. (BLUD)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
CEO:
Employees:
3130 GATWAY, PO BOX 5625, NORCROSS, GA 30091
770 441 2051

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 1.885 Billion Shares Outstanding70.296 Million Avg 30-day Volume 3.245 Million
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue0.0 Debt to Equity6.682 EBITDA342.798 Million
Price to Book Value0.0 Operating Margin19.225900000000003 Enterprise Value2.068 Billion
Current Ratio1.534 EPS Growth0 Quick Ratio1.726
1 Yr BETA 0.7005 52-week High/Low 0.0 / Profit Margin-12.8718
Operating Cash Flow Growth-107.21 Free Cash Flow to Firm (FCFF) TTM 4.365 Billion Free Cash Flow to Equity (FCFE) TTM198.048 Million
Altman Z-Score-0.0818
View SEC Filings from BLUD instead.

View recent insider trading info

Immucor Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding BLUD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BLUD

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2011-08-26 by FLYNT RICHARD A JR
  • 4: filed on 2011-08-24 by Morfit G Mason
  • 4: filed on 2011-08-24 by ROSEN JOSEPH
  • 4: filed on 2011-08-24 by PERKINS CHRIS E
  • 4: filed on 2011-08-23 by LANCASTER RONNY B
  • 4: filed on 2011-08-23 by CLOUSER JAMES
  • 4: filed on 2011-08-23 by MINTZ PAUL
  • 4: filed on 2011-08-23 by HOLLAND PAUL V MD
  • 4: filed on 2011-08-23 by MOISE PHILIP H
  • 4: filed on 2011-08-23 by FLYNT RICHARD A JR

    • Events (8k)

  • 8-K: filed on 2017-07-18:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-06-23:
    Item 8.01: Other Events
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2017-06-21:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-06-20:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-04-19:
    Item 2.05: Cost Associated with Exit or Disposal Activities
  • 8-K: filed on 2016-05-10:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ROSEN JOSEPH

    • Director
    		 No longer subject to file 2011-08-19 0

    LEVINE JOSHUA PRESIDENT AND CEO

    • Officer
    • Director
    		 No longer subject to file 2011-08-19 0

    PERKINS CHRIS E

    • Director
    		 No longer subject to file 2011-08-19 0

    LANCASTER RONNY B

    • Director
    		 No longer subject to file 2011-08-19 0

    FLYNT RICHARD A JR SVP AND CFO

    • Officer
    		 No longer subject to file 2011-08-19 0

    MORFIT G MASON

    • Director
    		 No longer subject to file 2011-08-19 0

    VALUEACT HOLDINGS, L.P.

    VALUEACT CAPITAL MASTER FUND, L.P.

    VA PARTNERS I, LLC

    VALUEACT CAPITAL MANAGEMENT, L.P.

    VALUEACT CAPITAL MANAGEMENT, LLC

    VALUEACT HOLDINGS GP, LLC

    • 10% Owner
    • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
    		 No longer subject to file 2011-08-19 0

    MOISE PHILIP H EVP, GENERAL COUNSEL

    • Officer
    		 No longer subject to file 2011-08-19 0

    CLOUSER JAMES

    • Director
    		 No longer subject to file 2011-08-19 0

    HOLLAND PAUL V MD

    • Director
    		 No longer subject to file 2011-08-19 0

    MINTZ PAUL

    • Director
    		 No longer subject to file 2011-08-19 0

    DE CHIRICO GIOACCHINO

    • FORMER CEO & PRESIDENT
    		 No longer subject to file 2011-06-09 0

    CROUSE GEOFFREY COO

    • Officer
    		 0 2010-07-16 0

    VALUEACT SMALLCAP MANAGEMENT, L.P.

    VALUEACT SMALLCAP MASTER FUND, L.P.

    VA SMALLCAP PARTNERS, LLC

    VALUEACT SMALLCAP MANAGEMENT, LLC

    LOCKWOOD DAVID JAMES

    • 10% Owner
    • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
    		 1,372,671 2010-04-27 0

    EATZ RALPH A CSO

    • Officer
    		 322,215 2009-06-04 0

    HOKETSU HIROSHI

    • Director
    		 61,022 2009-06-04 0

    BOWERS ROSWELL S

    • Director
    		 16,318 2008-11-12 0

    HARRIS JOHN

    • Director
    		 2,181 2008-07-31 0

    GOLDSTEIN JACK

    • Director
    		 1,505 2008-06-05 0

    GOLDMAN MICHAEL S

    • Director
    		 2,350 2008-06-05 0

    LANSON DIDIER L

    • DIRECTOR, EUROPEAN OPERATIONS
    		 4,095 2007-08-02 0

    WADDY PATRICK D CFO

    • Officer
    		 76,654 2007-06-08 0

    GALLUP EDWARD

    • OUTGOING CEO
    		 0 2007-05-31 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments